- Home
- TAOP vs GLMD Comparison
TAOP vs GLMD Comparison
Compare TAOP & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAOP
- GLMD
- Stock Information
- Founded
- TAOP 1993
- GLMD 2000
- Country
- TAOP China
- GLMD Israel
- Employees
- TAOP N/A
- GLMD N/A
- Industry
- TAOP Computer Software: Prepackaged Software
- GLMD Biotechnology: Pharmaceutical Preparations
- Sector
- TAOP Technology
- GLMD Health Care
- Exchange
- TAOP Nasdaq
- GLMD Nasdaq
- Market Cap
- TAOP 2.7M
- GLMD 3.0M
- IPO Year
- TAOP N/A
- GLMD 2014
- Fundamental
- Price
- TAOP $4.40
- GLMD $1.81
- Analyst Decision
- TAOP
- GLMD Hold
- Analyst Count
- TAOP 0
- GLMD 1
- Target Price
- TAOP N/A
- GLMD N/A
- AVG Volume (30 Days)
- TAOP 81.4K
- GLMD 364.3K
- Earning Date
- TAOP 07-11-2025
- GLMD 05-22-2025
- Dividend Yield
- TAOP N/A
- GLMD N/A
- EPS Growth
- TAOP N/A
- GLMD N/A
- EPS
- TAOP N/A
- GLMD N/A
- Revenue
- TAOP $36,672,512.00
- GLMD N/A
- Revenue This Year
- TAOP N/A
- GLMD N/A
- Revenue Next Year
- TAOP N/A
- GLMD N/A
- P/E Ratio
- TAOP N/A
- GLMD N/A
- Revenue Growth
- TAOP N/A
- GLMD N/A
- 52 Week Low
- TAOP $3.56
- GLMD $1.15
- 52 Week High
- TAOP $29.40
- GLMD $23.80
- Technical
- Relative Strength Index (RSI)
- TAOP 37.36
- GLMD 61.13
- Support Level
- TAOP $3.70
- GLMD $1.63
- Resistance Level
- TAOP $5.00
- GLMD $1.94
- Average True Range (ATR)
- TAOP 0.86
- GLMD 0.12
- MACD
- TAOP -0.08
- GLMD 0.01
- Stochastic Oscillator
- TAOP 20.79
- GLMD 69.77
About TAOP Taoping Inc.
Taoping Inc is a provider of cloud-app technologies for smart city IoT platforms, digital advertising delivery, and other internet-based information distribution systems in China. Its operating segment includes Cloud-based Technology (CBT), Blockchain Technology (BT), and Traditional Information Technology (TIT). It generates maximum revenue from the CBT segment. CBT segment includes cloud-based products and services offered to customers in the private sector including new media, healthcare, education, and residential community management.
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.